The MS Academy is hosting a series of educational webinars to address some of the challenges with managing specific neurological conditions, or elements of neurological conditions, during the COVID-19 pandemic.

Please note that all session and slide content are the views of the Speakers, not the MS Academy. The content of the recording is the speaker’s personal opinion at the time of recording. Due to the everchanging situation, advice given at the time of recording is subject to change.

Upcoming webinars

How to manage bladder problems and UTIs remotely

14 December 2020 | Ruth Stross, Collette Haslam, Dr Niraj Mistry & Mark Webb

End of life care for people with MS

9 December 2020 | Ruth Stross, Nicola Faulkner, Dr Eli Silber & Megan Roberts

Preparing patients for their online follow up appointments

20 November 2020 | Dr Andrea Stennett, Amy Harbour & Dr Ide Smets

How to diagnose and manage bowel problems remotely

16 November 2020 | Prof Anton Emmanuel & Julie Storrie

Anti-CD20 therapies and COVID-19

30 October 2020 | Prof Gavin Giovannoni & Prof David Baker

COVID-19 MS update: evidence at last

22 October 2020 | Dr Nikos Evangelou, Dr Christopher Allen, Dr Afagh Garjani & Terri Worthington

The above meetings have been sponsored by Roche Products Limited and Bristol-Myers Squibb Pharmaceuticals Limited. The sponsors have had no control over the educational content of this activity.



Use of steroids and COVID-19 risk; is there a need to modify their use?

30 September 2020 | Prof Gavin Giovannoni & Joela Mathews

Siponimod – how do we give patients with secondary progressive MS hope?

10 July 2020 | Dr David Paling, Prof Gavin Giovannoni & Dr Rachel Farrell

Neuro rehabilitation – now and the future

1 July 2020 | Ruth Stross, Dr Agne Straukiene, Margie Leong, Sherridan Daly, Kim Knight, Camille Whitehead & Jacqueline Rose

MS – the future

26 June 2020 | Prof Gavin Giovannoni, Dr Ruth Dobson, Dr Stefano Pluchino and Prof Anna Williams

New service models

19 June 2020 | Prof Gavin Giovannoni, Alyson McGregor, Bernadette Porter, Amy Harbour & George Pepper

Q&A with your MS pharmacist about DMTs

8 June 2020 | Joela Mathews & Rachel Dorsey-Campbell

Formalising remote management of MS – Making sure when we get back to normal we continue to use what we have learnt

4 June 2020 | Prof Jeremy Hobart, Dr David Paling, Dr Wallace Brownlee & Daisy Cam

Vaccination – Will our patients be able to respond to a Coronavirus vaccine?

20 May 2020 | Prof David Baker & Prof Gavin Giovannoni

Update of COVID-19 and MS – Morbidity and mortality figures

13 May 2020 | Prof Richard Nicholas, Prof Marco Salvetti & Prof Gavin Giovannoni

Lymphopaenia – What is a safe lymphocyte count?

6 May 2020 | Prof Gavin Giovannoni

How to prepare in the event of you getting COVID-19

29 April 2020 | Prof Gavin Giovannoni, George Pepper, Megan Roberts & Jody Barber

#MSCovid19 Question Time

22 April 2020 | Prof Gavin Giovannoni, George Pepper, Joela Mathews, Phillip Anderson & Megan Roberts

Ask the experts – #MSCovid19 Q&A for MSers

17 April 2020 | Prof Jeremy Hobart & Dr David Paling

Running a remote MS service during the COVID-19 pandemic

14 April 2020 | Dr Niall MacDougall, Dr Brendan McLean, Rachel Morrison & Joela Mathews

MS Nurses/Practitioners – Mind Health in Times of Crisis

9 April 2020 | Jo Johnson & Ruth Stross

Ask the experts – #MSCovid19 mind health session for MSers

6 April 2020 | Jo Johnson, Prof Jeremy Hobart, George Pepper & Ruth Stross

#MSCovid19 Question Time

3 April 2020 | Prof Jeremy Hobart, Rachel Dorsey-Campbell & Sarah White

#MSCovid19 Question Time

27 March 2020 | Prof Gavin Giovannoni, David Martin, George Pepper, Phillip Anderson & Rachel Dorsey-Campbell

The above meetings have been sponsored by Roche Products Limited. Roche Products Limited has had no control over the educational content of this activity.

Managing MS remotely during the COVID-19 pandemic

18 March 2020 | Prof Gavin Giovannoni



Upcoming webinars


Webinars for MSers


Endorsed by

MS Trust logo         MS Socity logo